- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Population Outcomes and Return on Value With CGMs
Experts discuss the metrics used to evaluate continuous glucose monitoring (CGM)'s comprehensive return on investment, including both cost savings and quality measure performance, and identify which patient populations demonstrate the strongest combined benefits in costs, quality measures, and outcomes, along with how these groups are prioritized for CGM access.
EP: 1.CGM: Redefining Type 2 Diabetes Management
EP: 2.Key Benefits of CGM Technology
EP: 3.CGM's Impact on Clinical Inertia
EP: 4.CGM vs Traditional Monitoring
EP: 5.Understanding CGM Metrics
EP: 6.Health Care System Integration
EP: 7.CGM Coverage and Access
EP: 8.Implementation Barriers
EP: 9.Overcoming Access Challenges
EP: 10.Adoption Strategies
EP: 11.The Metro Nashville Public Schools Initiative
EP: 12.Health Care Quality Impact
EP: 13.Population Outcomes and Return on Value With CGMs
EP: 14.Long-Term Outcomes Assessment
EP: 15.Closing Perspectives
Video content above is prompted by the following:
- What metrics do you use to evaluate CGM's comprehensive return on investment, including both cost savings and quality measure performance?
- Which patient populations demonstrate the strongest combined benefits in costs, quality measures, and outcomes, and how do you prioritize these groups for CGM access?
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Health Policy in Flux: Trump Administration Updates
May 20th 2025HHS announces it is taking steps to implement President Trump’s Executive Order on prescription drug pricing. Keep up with the latest moves made in health policy under President Donald Trump's second administration. This timeline will be updated as orders and policy progress.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
